ArticleJAMA health forum2024
Experience of Personal Loss Due to Drug Overdose Among US Adults.
Article in JAMA health forum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Study protocol for a randomized trial examining a peer grief support approach for people grieving drug overdose deaths.Addiction science & clinical practice · 2026Trial
- Factors Associated with Mental Health Outcomes Following Drug Overdose Loss.Behavioral sciences (Basel, Switzerland) · 2026Article
- U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences.Rand health quarterly · 2026Article
- Brief report: A cross-sectional survey of provider engagement with family members following patient drug overdose death.The American journal on addictions · 2026Article
- U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.Rand health quarterly · 2026Article
- Projected Outcomes of Reducing Federal Funding for Syringe Service Programs via Executive Order.JAMA network open · 2026Article
- Impacts of Risk Perceptions of Secondhand Exposure to Drugs on Intent to Leave Among Transit Operators: Transit Operators' Perceived Risk of Drug Exposure.Journal of occupational and environmental medicine · 2026Article
- Barriers beyond behavior: structural determinants of behavioral health treatment disparities among Hispanics in the U.S.Frontiers in public health · 2026Article
- Ethical considerations of wastewater-based disease surveillance-a qualitative interview study.Frontiers in public health · 2026Article
- A nation of caregivers: past, present, and future expectations of caregiving.Health affairs scholar · 2026Article
- Usability of Mixed Reality for Naloxone Training: Iterative Development and Field Testing of ReviveXR.Healthcare (Basel, Switzerland) · 2025Article
- Support for Care Economy Policies by Political Affiliation and Caregiving Responsibilities.JAMA health forum · 2025Article
- Sociodemographic and clinical characteristics associated with overdose among patients with a substance-related diagnosis in the emergency department of Southern California.Harm reduction journal · 2025Article
- An Epigenetic Mechanism Promoting Heroin Relapse After Prolonged Abstinence.Biological psychiatry · 2025Article
- A randomized, sham-controlled clinical trial to evaluate the NET Device™ for reducing withdrawal symptom severity during opioid discontinuation.Frontiers in psychiatry · 2025Article
- Post-discharge use of opioids, psychostimulants, and treatment medications following residential opioid discontinuation with NET Device™ monotherapy.Frontiers in psychiatry · 2025Article
- Drug involvement variations in overdose death spikes: county-level analysis in Massachusetts.BMJ public health · 2025Article
- Evaluating Stigma Toward Individuals With Substance Use Disorder Among Prelicensure Nursing Students.Nurse educatorArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Since 1999, over 1 million people have died of a drug overdose in the US. However, little is known about the bereaved, meaning their family, friends, and acquaintances, and their views on the importance of addiction as a policy priority. Objectives: To quantify the scope of the drug overdose crisis in terms of personal overdose loss (ie, knowing someone who died of a drug overdose) and to assess the policy implications of this loss. Design, Setting, and Participants: This cross-sectional study used data from a nationally representative survey of US adults (age ≥18 years), the fourth wave of the COVID-19 and Life Stressors Impact on Mental Health and Well-Being (CLIMB) study, which was conducted from March to April 2023. Main Outcomes and Measures: Respondents reported whether they knew someone who died of a drug overdose and the nature of their relationship with the decedent(s). They also reported their political party affiliation and rated the importance of addiction as a policy issue. Logistic regression models estimated the associations between sociodemographic characteristics and political party affiliation and the probability of experiencing a personal overdose loss and between the experience of overdose loss and the perceived salience of addiction as a policy issue. Survey weights adjusted for sampling design and nonresponse. Results: Of the 7802 panelists invited to participate, 2479 completed the survey (31.8% response rate); 153 were excluded because they did not know whether they knew someone who died of a drug overdose, resulting in a final analytic sample of 2326 (51.4% female; mean [SD] age, 48.12 [0.48] years). Of these respondents, 32.0% (95% CI, 28.8%-34.3%) reported any personal overdose loss, translating to 82.7 million US adults. A total of 18.9% (95% CI, 17.1%-20.8%) of all respondents, translating to 48.9 million US adults, reported having a family member or close friend die of drug overdose. Personal overdose loss was more prevalent among groups with lower income (<$30 000: 39.9%; ≥$100 000: 26.0%). The experience of overdose loss did not differ across political party groups (Democrat: 29.0%; Republican: 33.0%; independent or none: 34.2%). Experiencing overdose loss was associated with a greater odds of viewing addiction as an extremely or very important policy issue (adjusted odds ratio, 1.37; 95% CI, 1.09-1.72) after adjustment for sociodemographic and geographic characteristics and political party affiliation. Conclusions and Relevance: This cross-sectional study found that 32% of US adults reported knowing someone who died of a drug overdose and that personal overdose loss was associated with greater odds of endorsing addiction as an important policy issue. The findings suggest that mobilization of this group may be an avenue to facilitate greater policy change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.